Aptevo Therapeutics Income Statement (2015-2025) | APVO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Revenue & cost
Revenue (Quarter)	2.42M	3.11M	3.10M	3.67M	3.11M
Cost of Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Research & Development (Quarter)	5.36M	4.72M	4.37M	4.54M	4.87M	3.87M	4.48M	4.67M	4.17M	5.46M	3.89M	3.59M	3.75M	3.64M	3.10M	3.88M	3.63M	3.33M	4.04M	3.54M
Selling, General & Administrative (Quarter)	3.95M	4.11M	3.48M	3.16M	3.86M	3.70M	3.31M	3.01M	3.59M	2.72M	2.67M	2.79M	3.23M	2.38M	2.11M	2.50M	2.85M	2.90M	3.57M	2.46M
Other Operating Expenses (Quarter)									9.65M
Operating Expenses (Quarter)	9.31M	8.83M	7.85M	7.71M	8.72M	7.56M	7.78M	7.68M	7.76M	8.18M	6.56M	6.38M	6.98M	6.02M	5.21M	6.38M	6.48M	6.23M	7.61M	6.00M
Operating Income (Quarter)	-6.89M	-5.72M	-4.75M	-4.04M	-5.61M	-7.56M	-7.78M	-7.68M	-7.76M	-8.18M	-6.56M	-6.38M	-6.98M	-6.02M	-5.21M	-6.38M	-6.48M	-6.23M	-7.61M	-6.00M
EBIT (Quarter)	-6.89M	-5.72M	-4.75M	-4.04M	-5.61M	-7.56M	-7.78M	-7.68M	-7.76M	-8.18M	-6.56M	-6.38M	-6.98M	-6.02M	-5.21M	-6.38M	-6.48M	-6.23M	-7.61M	-6.00M
Non-operating items
Other Non Operating Income (Quarter)	-0.78M	-2.34M	-2.33M	-2.56M	-2.26M	37.18M	-0.03M		-0.07M	0.23M	0.23M	0.19M	0.15M	0.14M	0.11M	0.07M	0.07M	0.02M	0.06M	0.19M
Non Operating Income (Quarter)	-0.78M	-2.34M	-2.33M	-2.56M	-2.26M	-1.76M	-0.03M	0.02M	-0.07M	0.23M	0.23M	0.19M	0.15M	0.14M	0.11M	0.07M	0.07M	0.02M	0.06M	0.19M
Net income details
EBT (Quarter)	-6.89M	-5.72M	-4.75M	-4.04M	-5.61M	-7.56M	-7.78M	-7.68M	-7.76M	-8.18M	-6.56M	-6.38M	-6.98M	-6.02M	-5.21M	-6.38M	-6.48M	-6.23M	-7.61M	-6.00M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-7.26M	-7.93M	-7.00M	-7.22M	-7.70M	28.01M	-7.81M	-5.16M	2.77M	-7.95M	-6.33M	-5.90M	-6.83M	-5.88M	-5.10M	-6.31M	-6.41M	-6.20M	-7.55M	-5.81M
Income from Continuing Operations (Quarter)	-6.89M	-5.72M	-4.75M	-4.04M	-5.61M	-7.56M	-7.78M	-7.68M	-7.76M	-8.18M	-6.56M	-6.38M	-6.98M	-6.02M	-5.21M	-6.38M	-6.48M	-6.23M	-7.61M	-6.00M
Consolidated Net Income (Quarter)	0.41M	0.13M	0.08M	0.33M	0.18M	0.15M	0.17M	0.52M	0.95M			0.29M					-6.48M	-6.23M	-7.61M	-6.00M
Income towards Parent Company (Quarter)	0.41M	0.13M	0.08M	0.33M	0.18M	0.15M	0.17M	0.52M	0.95M			0.29M					-6.48M	-6.23M	-7.61M	-6.00M
Preferred Dividend Payments (Quarter)																			1.48M	0.09M
Net Income towards Common Stockholders (Quarter)	0.41M	0.13M	0.08M	0.33M	0.18M	0.15M	0.17M	0.52M	0.95M			0.29M			-5.10M	-6.31M	-6.48M	-6.23M	-9.03M	-5.90M
Additional items
EPS (Basic) (Quarter)	-1.74	-1.75	-1.43	-1.27	-1.55	5.58	-1.50	-0.95	5.93			38.99	-368.21	-0.00M	-357.86	-0.03M	-4.39	-8.40	-2.23	-75.85
EPS (Weighted Average and Diluted) (Quarter)		-1.75	-1.43	-1.27	0.04	5.58	-1.50	-0.95	5.93			38.99	-368.21	-0.00M	-357.86	-0.03M	-4.39	-8.40	-2.23	-75.85
Shares Outstanding (Weighted Average) (Quarter)	4.42M	4.54M	4.62M	4.69M	4.94M	5.02M	5.09M	5.10M	0.16M	0.15M	0.29M	0.01M	0.02M	0.00M	0.01M	767.00	1.46M	12.59M	4.05M
Shares Outstanding (Diluted Average) (Quarter)		4.48M	4.62M	4.69M	4.94M	5.02M	5.09M	5.10M	0.16M	0.15M	0.20M	0.01M	0.02M	0.00M	0.00M	767.00	1.46M	0.41M	4.05M
EBITDA (Quarter)	-6.89M	-5.72M	-4.75M	-4.04M	-5.61M	-7.56M	-7.78M	-7.68M	-7.76M	-8.18M	-6.56M	-6.38M	-6.98M	-6.02M	-5.21M	-6.38M	-6.48M	-6.23M	-7.61M	-6.00M
Interest Expenses (Quarter)
Tax Rate (Quarter)

Research Tools

Aptevo Therapeutics Income Statement (2015-2025) | APVO

Create an account

Sign In

Reset Password